Singapore – Esco Aster, a leading independent contract development and manufacturing organization with its patent ...
Singapore- Cells use nutrients such as glucose, amino acids and fat (lipids) to produce the energy to support the essent...
Singapore – Doctor Anywhere, a Singapore-based telehealth start up, has successfully raised S$5.6 million in a ser...
Singapore- Leading APAC healthcare platform, Fullerton Healthcare Corporation Limited and Microsoft Asia Pacific have an...
Prestige BioPharma and Alvogen announced that the two companies have entered into a binding agreement for the exclusive ...
Mundipharma has announced the extension of its strategic partnership with Kolon Life Science to market Invossa-K in Saud...
Singapore-based MiRXES has announced that it is providing the ID3EAL miRNA and other non-coding RNA detection technology...
Nanyang Technological University (NTU) has launched a suite of new research centres and laboratories to study the chroni...
Singapore - AUM Biosciences (AUM), a new company focused on the development of innovative and affordable oncology m...
Carmentix Pte. Ltd. is proud to announce a research collaboration with The University of Melbourne (UoM), The Chinese Un...
As part of an ongoing field study into curbing dengue transmissions in Singapore, local startup Orinno Technology has be...
Esco Group has entered into an agreement to acquire the remaining shares in AT Medical UAB, an Esco Ventures portfolio c...
Singapore – Researchers from A*STAR’s Singapore Immunology Network (SIgN) and Genome Institute of Singapore ...
Macrogen, Inc., a precision medicine biotechnology company, announced that it has established Macrogen Asia Pacific Pt...
Singapore- Royal Philips, a global leader in health technology, and the Singapore Institute of Advanced Medicine H...
Singapore- SGInnovate is presenting ARISE, Southeast Asia’s preeminent deep tech event at innovfest...
A group of scientists at Nanyang Technological University, Singapore (NTU Singapore) has developed a new way of seeing w...
Lion TCR, a Singapore-based clinical stage biotech firm has raised $ 20 million in a Series A funding round from new inv...
